Clinical Trial Update: A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 study update of neratinib (HKI-272) in combination with capecitabine in Japanese patients with advanced malignant solid tumors. Study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumors

Drugs mentioned

• Capecitabine (capecitabine)
• neratinib (HKI-272) (neratinib)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Advanced Malignant Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2018-12-19